Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse Y Zhang, SA Sloan, LE Clarke, C Caneda, CA Plaza, PD Blumenthal, ... Neuron 89 (1), 37-53, 2016 | 1941 | 2016 |
New tools for studying microglia in the mouse and human CNS ML Bennett, FC Bennett, SA Liddelow, B Ajami, JL Zamanian, NB Fernhoff, ... Proceedings of the National Academy of Sciences 113 (12), E1738-E1746, 2016 | 1683 | 2016 |
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors SB Willingham, JP Volkmer, AJ Gentles, D Sahoo, P Dalerba, SS Mitra, ... Proceedings of the National Academy of Sciences 109 (17), 6662-6667, 2012 | 1590 | 2012 |
Single-cell RNA-seq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma S Darmanis, SA Sloan, D Croote, M Mignardi, S Chernikova, ... Cell reports 21 (5), 1399-1410, 2017 | 785 | 2017 |
Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma LI Gordon, D Harrington, J Andersen, J Colgan, J Glick, R Neiman, ... New England Journal of Medicine 327 (19), 1342-1349, 1992 | 425 | 1992 |
Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma M Monje, SS Mitra, ME Freret, TB Raveh, J Kim, M Masek, JL Attema, G Li, ... Proceedings of the National Academy of Sciences 108 (11), 4453-4458, 2011 | 331 | 2011 |
Immune evasion strategies of glioblastoma SM Razavi, KE Lee, BE Jin, PS Aujla, S Gholamin, G Li Frontiers in surgery 3, 11, 2016 | 251 | 2016 |
Effects of age and comorbidities on complication rates and adverse outcomes after lumbar laminectomy in elderly patients G Li, CG Patil, SP Lad, C Ho, W Tian, M Boakye Spine 33 (11), 1250-1255, 2008 | 204 | 2008 |
Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases B Atalar, LA Modlin, CYH Choi, JR Adler, IC Gibbs, SD Chang, ... International Journal of Radiation Oncology* Biology* Physics 87 (4), 713-718, 2013 | 160 | 2013 |
Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III DR Emlet, P Gupta, M Holgado-Madruga, CA Del Vecchio, SS Mitra, ... Cancer research 74 (4), 1238-1249, 2014 | 155 | 2014 |
Radiosurgery of glomus jugulare tumors: a meta-analysis ZD Guss, S Batra, CJ Limb, G Li, ME Sughrue, K Redmond, D Rigamonti, ... International Journal of Radiation Oncology* Biology* Physics 81 (4), e497-e502, 2011 | 134 | 2011 |
First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800 SE Miller, WS Tummers, N Teraphongphom, NS van den Berg, A Hasan, ... Journal of neuro-oncology 139, 135-143, 2018 | 126 | 2018 |
ReACT: Overall survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma. DA Reardon, J Schuster, DD Tran, KL Fink, LB Nabors, G Li, DA Bota, ... Journal of Clinical Oncology 33 (15_suppl), 2009-2009, 2015 | 123* | 2015 |
Rindopepimut with bevacizumab for patients with relapsed EGFRvIII-expressing glioblastoma (ReACT): results of a double-blind randomized phase II trial DA Reardon, A Desjardins, JJ Vredenburgh, DM O'Rourke, DD Tran, ... Clinical Cancer Research 26 (7), 1586-1594, 2020 | 121 | 2020 |
The incidence and significance of multiple lesions in glioblastoma RP Thomas, LW Xu, RM Lober, G Li, S Nagpal Journal of neuro-oncology 112, 91-97, 2013 | 115 | 2013 |
Surfactant protein-A–deficient mice display an exaggerated early inflammatory response to a β-resistant strain of influenza A virus G Li, J Siddiqui, M Hendry, J Akiyama, J Edmondson, C Brown, L Allen, ... American journal of respiratory cell and molecular biology 26 (3), 277-282, 2002 | 115 | 2002 |
Current vaccine trials in glioblastoma: a review LW Xu, KKH Chow, M Lim, G Li Journal of immunology research 2014, 2014 | 97 | 2014 |
The future of glioblastoma therapy: synergism of standard of care and immunotherapy MA Patel, JE Kim, J Ruzevick, G Li, M Lim Cancers 6 (4), 1953-1985, 2014 | 93 | 2014 |
Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas CA Del Vecchio, G Li, AJ Wong Expert review of vaccines 11 (2), 133-144, 2012 | 89 | 2012 |
EGF receptor variant III as a target antigen for tumor immunotherapy G Li, AJ Wong Expert review of vaccines 7 (7), 977-985, 2008 | 84 | 2008 |